• c-KIT Mutation Analysis, Blood, Bone Marrow
  • Clonazepam, Serum
  • Legionella infection
  • Brain-derived Neurotrophic Factor (BDNF) Genotyping
  • 18-Hydroxycorticosterone
  • CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
  • Vanillylmandelic Acid (VMA) and Homovanillic Acid (HVA), Random, Urine
  • Bacterial Culture, Upper Respiratory
  • Fructosamine (Glycated Protein)
  • Human Papillomavirus (HPV), Low-Risk, DNA In Situ Hybridization
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Sarcoma Gene Mutation, Fusion and Rearrangement Panel, NGS
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Sarcoma Gene Mutation, Fusion and Rearrangement Panel, NGS
Medical Test

Additional Testing
Access to Sarcoma Gene Mutation, Fusion and Rearrangement Panel, NGS is restricted.